Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiviral drugs are used to treat viral infections such as human immunodeficiency virus (HIV), hepatitis, and influenza. Several investigational drugs are currently being developed for the treatment of HIV infection.
North America accounts for the majority of the market share due to the presence of major market players, advanced medical infrastructure, and increased awareness of viral diseases. The global antiviral drugs market size is expected to register a CAGR of -2.2% over the forecast period, 2020-2026.
The prevalence of viral infections such as HIV, hepatitis, respiratory syncytial virus (RSV), and influenza will drive the demand for antiviral drugs. However, increased precautions and awareness of vaccines for viral infections will limit the growth of the antiviral market.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Antiviral Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Antiviral Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antiviral Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Roche
GlaxoSmithKline
AbbVie
Gilead Sciences
Novartis
Merck
Bristol-Myers Squibb
Johnson & Johnson
By Type:
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
By End-User:
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antiviral Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Antiviral Drugs Market Size and Growth Rate of Reverse Transcriptase Inhibitors from 2016 to 2027
-
1.3.2 China Antiviral Drugs Market Size and Growth Rate of Protease Inhibitors from 2016 to 2027
-
1.3.3 China Antiviral Drugs Market Size and Growth Rate of Fusion Inhibitors from 2016 to 2027
-
1.3.4 China Antiviral Drugs Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Antiviral Drugs Market Size and Growth Rate of Hepatitis Therapeutics from 2016 to 2027
-
1.4.2 China Antiviral Drugs Market Size and Growth Rate of HIV/AIDS Therapeutics from 2016 to 2027
-
1.4.3 China Antiviral Drugs Market Size and Growth Rate of Herpes Therapeutics from 2016 to 2027
-
1.4.4 China Antiviral Drugs Market Size and Growth Rate of Influenza Therapeutics from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antiviral Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antiviral Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Reverse Transcriptase Inhibitors
-
3.4.2 Market Size and Growth Rate of Protease Inhibitors
-
3.4.3 Market Size and Growth Rate of Fusion Inhibitors
-
3.4.4 Market Size and Growth Rate of Immune System Modulators
4 Segmentation of Antiviral Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antiviral Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antiviral Drugs in Hepatitis Therapeutics
-
4.4.2 Market Size and Growth Rate of Antiviral Drugs in HIV/AIDS Therapeutics
-
4.4.3 Market Size and Growth Rate of Antiviral Drugs in Herpes Therapeutics
-
4.4.4 Market Size and Growth Rate of Antiviral Drugs in Influenza Therapeutics
5 Market Analysis by Regions
-
5.1 China Antiviral Drugs Production Analysis by Regions
-
5.2 China Antiviral Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Antiviral Drugs Landscape Analysis
-
6.1 North China Antiviral Drugs Landscape Analysis by Major Types
-
6.2 North China Antiviral Drugs Landscape Analysis by Major End-Users
7 Central China Antiviral Drugs Landscape Analysis
-
7.1 Central China Antiviral Drugs Landscape Analysis by Major Types
-
7.2 Central China Antiviral Drugs Landscape Analysis by Major End-Users
8 South China Antiviral Drugs Landscape Analysis
-
8.1 South China Antiviral Drugs Landscape Analysis by Major Types
-
8.2 South China Antiviral Drugs Landscape Analysis by Major End-Users
9 East China Antiviral Drugs Landscape Analysis
-
9.1 East China Antiviral Drugs Landscape Analysis by Major Types
-
9.2 East China Antiviral Drugs Landscape Analysis by Major End-Users
10 Northeast China Antiviral Drugs Landscape Analysis
-
10.1 Northeast China Antiviral Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Antiviral Drugs Landscape Analysis by Major End-Users
11 Southwest China Antiviral Drugs Landscape Analysis
-
11.1 Southwest China Antiviral Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Antiviral Drugs Landscape Analysis by Major End-Users
12 Northwest China Antiviral Drugs Landscape Analysis
-
12.1 Northwest China Antiviral Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Antiviral Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Roche
-
13.1.1 Roche Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 GlaxoSmithKline
-
13.2.1 GlaxoSmithKline Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AbbVie
-
13.3.1 AbbVie Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Gilead Sciences
-
13.4.1 Gilead Sciences Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis
-
13.5.1 Novartis Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Merck
-
13.6.1 Merck Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bristol-Myers Squibb
-
13.7.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Johnson & Johnson
-
13.8.1 Johnson & Johnson Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Antiviral Drugs Market Size and Growth Rate of Reverse Transcriptase Inhibitors from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Protease Inhibitors from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Fusion Inhibitors from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Hepatitis Therapeutics from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of HIV/AIDS Therapeutics from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Herpes Therapeutics from 2016 to 2027
-
Figure China Antiviral Drugs Market Size and Growth Rate of Influenza Therapeutics from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Antiviral Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antiviral Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antiviral Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antiviral Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Antiviral Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Reverse Transcriptase Inhibitors
-
Figure Market Size and Growth Rate of Protease Inhibitors
-
Figure Market Size and Growth Rate of Fusion Inhibitors
-
Figure Market Size and Growth Rate of Immune System Modulators
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antiviral Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antiviral Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hepatitis Therapeutics
-
Figure Market Size and Growth Rate of HIV/AIDS Therapeutics
-
Figure Market Size and Growth Rate of Herpes Therapeutics
-
Figure Market Size and Growth Rate of Influenza Therapeutics
-
Table China Antiviral Drugs Production by Regions
-
Table China Antiviral Drugs Production Share by Regions
-
Figure China Antiviral Drugs Production Share by Regions in 2016
-
Figure China Antiviral Drugs Production Share by Regions in 2021
-
Figure China Antiviral Drugs Production Share by Regions in 2027
-
Table China Antiviral Drugs Consumption by Regions
-
Table China Antiviral Drugs Consumption Share by Regions
-
Figure China Antiviral Drugs Consumption Share by Regions in 2016
-
Figure China Antiviral Drugs Consumption Share by Regions in 2021
-
Figure China Antiviral Drugs Consumption Share by Regions in 2027
-
Table North China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table North China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Antiviral Drugs Consumption Share by Types in 2016
-
Figure North China Antiviral Drugs Consumption Share by Types in 2021
-
Figure North China Antiviral Drugs Consumption Share by Types in 2027
-
Table North China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure North China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure North China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Central China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Central China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Antiviral Drugs Consumption Share by Types in 2016
-
Figure Central China Antiviral Drugs Consumption Share by Types in 2021
-
Figure Central China Antiviral Drugs Consumption Share by Types in 2027
-
Table Central China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Central China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Central China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table South China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table South China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Antiviral Drugs Consumption Share by Types in 2016
-
Figure South China Antiviral Drugs Consumption Share by Types in 2021
-
Figure South China Antiviral Drugs Consumption Share by Types in 2027
-
Table South China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure South China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure South China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table East China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table East China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Antiviral Drugs Consumption Share by Types in 2016
-
Figure East China Antiviral Drugs Consumption Share by Types in 2021
-
Figure East China Antiviral Drugs Consumption Share by Types in 2027
-
Table East China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure East China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure East China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Antiviral Drugs Consumption Share by Types in 2016
-
Figure Northeast China Antiviral Drugs Consumption Share by Types in 2021
-
Figure Northeast China Antiviral Drugs Consumption Share by Types in 2027
-
Table Northeast China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Antiviral Drugs Consumption Share by Types in 2016
-
Figure Southwest China Antiviral Drugs Consumption Share by Types in 2021
-
Figure Southwest China Antiviral Drugs Consumption Share by Types in 2027
-
Table Southwest China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Antiviral Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Antiviral Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Antiviral Drugs Consumption Share by Types in 2016
-
Figure Northwest China Antiviral Drugs Consumption Share by Types in 2021
-
Figure Northwest China Antiviral Drugs Consumption Share by Types in 2027
-
Table Northwest China Antiviral Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Antiviral Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Antiviral Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Antiviral Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Antiviral Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Gilead Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences
-
Figure Sales and Growth Rate Analysis of Gilead Sciences
-
Figure Revenue and Market Share Analysis of Gilead Sciences
-
Table Product and Service Introduction of Gilead Sciences
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
